4D Molecular Therapeutics Ownership & Insider Activity - Benzinga

SPY761.11+0.15%QQQ704.88+0.07%BTC/USD80,508.60−0.70%DIA522.05+0.13%GLD366.33−0.08%TLT81.30−0.05%

4D Molecular Therapeutics Inc

FDMTNASDAQ

Trade with Public

Trade with Public

$10.80

-1.05-8.86%

Last update: Oct 23, 4:00 PM

Overview News Earnings Forecast Events Price Targets Financials SentimentOwnershipCompare Options Stock Report

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

4D Molecular Therapeutics Ownership & Insider Activity - Benzinga

4D Molecular Therapeutics Ownership & Insider Activity

4D Molecular Therapeutics (FDMT) institutional and insider ownership, recent insider transactions and ownership breakdown.

Net Insider Activity by Month

Purchases (90d)

0

Sales (90d)

5

$2.8M total

Net Activity

Net Selling

Net Value (90d)

-$2.8M

4D Molecular Therapeutics Insider Transactions (Last 6 Months)

See all insider trades →

Date	Insider	Title	Type	Shares	Price	Value
Oct 16, 2026	Scott Bizily	CHIEF LEGAL OFFICER	SELL-OPTIONS	—	$8.49	$14K
Oct 5, 2026	David Kirn	SEE REMARKS	SELL	58.333K	$12.92	$754K
Sep 16, 2026	Scott Bizily	CHIEF LEGAL OFFICER	SELL-OPTIONS	—	$8.89	$16K
Sep 14, 2026	David Kirn	SEE REMARKS	SELL	58.333K	$13.90	$811K
Sep 1, 2026	Scott Bizily	CHIEF LEGAL OFFICER	SELL-OPTIONS	—	$10.25	$4K
Aug 19, 2026	David Kirn	SEE REMARKS	SELL	19.076K	$9.95	$881K
Aug 13, 2026	Scott Bizily	CHIEF LEGAL OFFICER	SELL-OPTIONS	—	$8.12	$26K
Aug 4, 2026	David Kirn	SEE REMARKS	SELL	26.842K	$10.23	$275K
Aug 3, 2026	David Kirn	SEE REMARKS	SELL	12.415K	$10.05	$125K
Jul 9, 2026	David Kirn	SEE REMARKS	SELL	58.333K	$12.64	$737K
Jun 30, 2026	Scott Bizily	CHIEF LEGAL OFFICER	SELL-OPTIONS	—	$10.10	$51K
Jun 23, 2026	Scott Bizily	CHIEF LEGAL OFFICER	SELL-OPTIONS	—	$8.07	$77K
Jun 22, 2026	David Kirn	SEE REMARKS	SELL	114.746K	$10.47	$1.2M
Jun 1, 2026	David Kirn	SEE REMARKS	SELL	1.922K	$10.02	$19K